CPhI Festival of Pharma
08-Oct-2020 By Jenni Spinner
The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.
10-Jul-2019 By Ben Hargreaves
The pharmaceutical processing seals market is set to grow by a CAGR of 6% through to 2023, according to a report by TechNavio.
23-May-2019 By Maggie Lynch
Navitas has acquired KAI Research to expand its trial site footprint in North America and Africa as well as bolster its ability to manage clinical trials in a number of research areas.
12-Apr-2019 By Ben Hargreaves
The global API market will achieve a CAGR of 6.8% running up to 2026, taking the total value to $268bn, a report suggests.
08-Jan-2018 By Melissa Fassbender
Sekisui XenoTech hired in record numbers in 2017 as it anticipates 10% or higher growth over the next couple of years fueled by demand for drug-drug interaction studies.
01-Nov-2017 By Melissa Fassbender
Factory CRO has acquired MileStone Research Organization as it looks to build the company’s footprint in North America.
16-May-2017 By Dan Stanton
With almost 40% of attendees coming from outside the US, the political climate has had no effect on the latest CPhI franchise which starts today in Philadelphia.
16-May-2017 By Melissa Fassbender
Flamma has opened a new cGMP workshop and R&D Center in Dalian, China and is looking to add capacity at several other sites as part of its “Flamma 2020 plan.”
23-Aug-2016 By Melissa Fassbender
The Eagle is MHI’s Americanized version of its PF-D1S – a compact, servo-driven blister machine, and the company’s first entrance into the North American marketplace.
16-Jun-2016 By Gareth Macdonald
Famar has said it will consider buying other US FDA approved facilities in Europe and North America.
24-May-2016 By Melissa Fassbender
Parexel recently opened a new North American Coordination Hub and Distribution Center in Pennsylvania, which will provide customers with clinical trial supplies and logistics services.
18-Apr-2016 By Dan Stanton
European CDMO Famar says it will continue making products on behalf of Bayer after acquiring a Canadian manufacturing facility from the firm.
13-Apr-2016 By Melissa Fassbender
WellSpring Pharma Services has announced a $3 million capital investment in new equipment in addition to a new strategic partnership with IDT Australia to manufacture drugs targeting the US market.
05-Nov-2015 By Dan Stanton
Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.
07-Sep-2015 By Gareth Macdonald
Almac has launched its trial drug home delivery service in Europe citing demand it has seen since rolling out the service in North America.
PEOPLE ON THE MOVE
01-Jun-2015 By Fiona BARRY
Plus cannabinoid drugmaker moves into North America, and more from our weekly IPT column.
07-May-2015 By Zachary Brennan
As competition and pricing get fiercer for CRO Charles River Laboratories, the company is looking to save about $35m from new efficiencies in its RMS (Research Models and Services) business, Jim Foster, chairman, president and CEO of CRL, told investors...
02-Oct-2014 By Zachary Brennan
China-based WuXi PharmaTech has acquired CRO XenoBiotic Laboratories (XBL) to bolster its bioanalytical and DMPK (Drug Metabolism and Pharmacokinetics)/ADME (absorption, distribution, metabolism, and excretion) services. Financial terms were not disclosed....
04-Aug-2014 By Zachary Brennan
Quintiles CEO Tom Pike told investors last week that the company is seeing “very strong demand from the larger pharmaceutical firms because their pipelines are full right now,” and at the same time, small biotech, with their plethora of funding, are starting...
21-Jul-2014 By Zachary Brennan
India-based Glenmark Pharmaceuticals has announced plans to set up a new oral solid dosage manufacturing facility in North Carolina.
08-Jul-2014 By Gareth Macdonald
Finished dosage form and API manufacturer Xellia has acquired a US plant from Fresenius Kabi in a deal it says enhances supply chain security.
06-May-2014 By Dan Stanton
Bayer says it will become the OTC leader in North America having acquired Merck & Co.’s consumer health business for $14.2bn (€10.2bn), in the latest shift in Big Pharma assets.
DISPATCHES FROM INTERPHEX
20-Mar-2014 By Dan Stanton
Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.
04-Feb-2014 By Fiona BARRY
Pharmaceutical services provider UDG Healthcare (formerly United Drug) announced today the integration of its sales, marketing and medical service divisions into one group, named Ashfield.
17-Oct-2013 By Zachary Brennan
CMO Jubilant LifeSciences is expanding at least four of its five manufacturing plants in the US and India as growth continues.
26-Aug-2013 By Dan Stanton
Novo Nordisk's North American affiliate has a new President and more news from drug delivery firm Enteris - welcome to in-Pharmatechnologist.com' People on the Move.
24-Jul-2013 By Zachary Brennan
With the Chinese NAP (nucleic acid purification) market expected to grow more than 8% over the next year and no clear market leaders, companies are looking to take control of the industry space.
02-Jul-2013 By Dan Stanton
Pharma firms are returning to European and North American manufacturers as quality issues and rising costs have lost India and China some of its ‘Eastern promise,’ according to industry experts.
ATMI has opened a development and testing lab in the US to let customers test its single-use production and technologies.
News from CPhI
25-Oct-2012 By Gareth Macdonald
CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.
Drug industry customers in Western Europe drove the modest gains achieved by GEA pharmaceutical business in Q2 2012.
14-May-2012 By Nick Taylor
Catalent reported a dip in third quarter contract packaging sales and volumes after a client insourced work.
BASF has announced plans for a new formic acid production plant in the US, citing the pharmaceutical industry among its key customer targets.
26-Apr-2012 By Nick Taylor
Bioprocess sales at Sartorius jumped 20 per cent in the first quarter on strong demand for single-use filters and bags.
21-Mar-2012 By Nick Taylor
Teva will try to use different delivery devices for biosimilars to gain an edge over innovator products, its North American CEO said.
13-Mar-2012 By Gareth Macdonald
Preclinical CRO CiToxLAB has added inhalation testing capacity, citing growing demand from Pharmas and chemicals firms as key driver for the investment.
Cyprotex invests to meet demand for cell-based preclinical tox
08-Nov-2011 By Gareth Macdonald
Cyprotex says increasing demand for cell-based preclinical toxicology services in North America prompted facility expansion plan.
VaxyGen & Georgia State join for protein purification services
20-Oct-2011 By Nick Taylor
VaxyGen is working with Georgia State University (GSU) to offer protein purification, optimisation and production services.
JSS & Venn partner to offer transatlantic clinical services
JSS Medical Research has bought Canadian assets from Venn Life Sciences as part of a joint-venture spanning North America and Europe.
vivoPharma opens US preclinical facility
14-Sep-2011 By Gareth Macdonald
Australian preclinical services firm vivoPharma has opened a new vivarium and laboratory facility in the US as part of an effort to expand its global reach.
Top 10 CMOs visualised by revenue and employment
Outsourcing-Pharma looks at the revenue and employment levels of the top 10 contract manufacturing organisations (CMO).
Gerresheimer wants to buy into US plastic packaging sector
06-Jul-2011 By Gareth Macdonald
Gerresheimer is interested in a US acquisition as part of a bid to build in the North American plastic drug packaging sector.
Ropack begins stickpack manufacturing at new $9m facility
26-May-2011 By Alexandria Pesic
Canadian pharmaceutical packaging firm, Ropack, has begun stickpack production in its new state-of-the-art 15,000 sq. ft. dedicated manufacturing suite.
Appointments at PPD, Clinilabs, Clearstone and Clariant – People on the move
31-Mar-2011 By Nick Taylor
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PPD, Clinilabs, Clearstone and Clariant.
LAB Research's Canadian lender appoints receivers
22-Feb-2011 By Gareth Macdonald
Lab Research's main Canadian lender has obtained an order appointing receivers under section 243 of the bankruptcy and insolvency act after the firm's US private equity suitor lost interest in a takeover.
Clearstone focused on strategic partnerships & Asia in ‘11
17-Feb-2011 By Nick Taylor
Strategic partnerships and Asian expansion are the focus at Clearstone as it looks to grow revenues in its second year of operation.
AMRI posts Q4 loss on non-cash charges, but sees manufacturing rev gains
10-Feb-2011 By Alexandria Pešić
Albany Molecular Research Inc. (AMRI) has posted a fourth quarter loss for 2010 after charges relating to a non-cash goodwill and fixed asset impairment of $35.2m.
Lab Research continues strategic review with extended credit
31-Jan-2011 By Gareth Macdonald
Canadian CRO Lab Research says it has secured funds sufficient to help it complete the strategic review it began last year.
Oystar sells Brazilian unit to Masipack
Oystar has sold its Brazilian unit, Oystar Fabrima, to Sao Paulo-headquartered firm Masipack in an effort to focus its business on country’s the primary and secondary packaging markets.
BA buys Hill Top to expand in North America & dermatology
12-Jan-2011 By Nick Taylor
India-based BA Research has acquired Hill Top Research to expand its North American contract research capabilities.